Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 29;7(9):214.
doi: 10.3390/tropicalmed7090214.

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger

Anyirékun Fabrice Somé  1 , Issaka Zongo  1 , Issaka Sagara  2 , Alkassoum Ibrahim  3 , Césaire Damien Ahanhanzo  4 , Edoh Eddie Agbanouvi-Agassi  4 , Dona Alain Sayi  4 , Lea Pare Toe  1 , Zachari Kabré  1 , Frédéric Nikiéma  1 , Thomas Bazié  1 , Sylvin Ouédraogo  1 , Issiaka Sombié  4 , Alassane Dicko  2 , Eric Adehossi  3 , Jean-Bosco Ouédraogo  1 , Kounbobr Roch Dabiré  1
Affiliations

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger

Anyirékun Fabrice Somé et al. Trop Med Infect Dis. .

Abstract

This study aims to evaluate the factors influencing the adherence to the 2nd and 3rd doses of Amodiaquine (AQ) during seasonal malaria chemoprevention (SMC) in Burkina Faso, Mali, and Niger. Overall, 3132 people were interviewed during surveys between 2019 and 2020 in 15 health districts. In Burkina Faso, Mali, and Niger, the proportions of non-adherence were 4.15%, 5.60%, and 13.30%, respectively, for the 2nd dose and 3.98%, 5.60% and 14.39% for the 3rd dose. The main cause of non-adherence to the 2nd and 3rd doses was other illnesses in 28.5% and 29.78%, respectively, in Burkina Faso, 5.35% and 5.35% in Mali and 1.6% and 0.75% in Niger. It was followed by vomiting in 12.24% and 10.63% for Burkina and 2.45% and 3.78% in Niger. The last cause was refusal in 6.12% and 4.25% in Burkina, 33.9% and 15.25% in Mali and 0.8% and 1.51% in Niger. Non-adherence of doses related to parents was primarily due to their absence in 28.5% and 27.65% in Burkina, 16.07% and 16.07% in Mali and 7.37% and 6.06% in Niger. Traveling was the second cause related to parents in 12.24% and 12.76% in Burkina, 19.64% and 19.64% in Mali and 0.81% and 0.75% in Niger. Non-adherence related to community distributors was mainly due to missing the doses in 4.08% and 4.25% in Burkina, 23.21% and 23.21% in Mali, 77.04% and 76.51% in Niger. Our study reported very small proportions of non-adherence to 2nd and 3rd doses of SMC and identified the main causes of non-adherence. These findings will provide helpful information for policymakers and public health authorities to improve adherence to SMC.

Keywords: Burkina Faso; Mali; Niger; Plasmodium falciparum; seasonal malaria chemoprevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
SMC coverage in Burkina Faso, Mali and Niger.
See this image and copyright information in PMC

References

    1. World Health Organization . World Malara Report 2020: 20 Years of Global Progress and Challenges. WHO; Geneva, Switzerland: 2020.
    1. World Health Organization . WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum Malaria Control in Highly Seasonal Transmission Areas of the Sahel Sub-Region in Africa. WHO; Geneva, Switzerland: 2012.
    1. Greenwood B. Review: Intermittent preventive treatment—A new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop. Med. Int. Health. 2006;11:983–991. doi: 10.1111/j.1365-3156.2006.01657.x. - DOI - PubMed
    1. Cairns M., Roca-Feltrer A., Garske T., Wilson A.L., Diallo D., Milligan P.J., Ghani A.C., Greenwood B.M. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat. Commun. 2012;3:881. doi: 10.1038/ncomms1879. - DOI - PMC - PubMed
    1. Cisse B., Sokhna C., Boulanger D., Milet J., Ba E.H., Richardson K., Hallett R., Sutherland C., Simondon K., Simondon F., et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: A randomised, placebo-controlled, double-blind trial. Lancet. 2006;367:659–667. doi: 10.1016/S0140-6736(06)68264-0. - DOI - PubMed

LinkOut - more resources